ENvue Medical (FEED) Cash from Operations (2014 - 2026)

ENvue Medical (FEED) has reported Cash from Operations for 13 consecutive years, with -$2.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations rose 20.46% year-over-year to -$2.7 million in Q2 2026; TTM through Jun 2026 was -$11.6 million, a 90.65% decrease from a year earlier, with the FY2025 full-year figure at -$9.4 million, down 272.5% from the prior year.
• Cash from Operations was -$2.7 million for Q2 2026 at ENvue Medical, up from -$4.3 million in the prior quarter.
• Over five years, Cash from Operations peaked at -$491000.0 in Q4 2023 and troughed at -$4.3 million in Q1 2026.
• A 5-year average of -$1.6 million and a median of -$1.3 million in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 65.27% in 2023 and slumped 511.75% in 2025, its largest moves.
• Over 5 years, Cash from Operations stood at -$1.3 million in 2022, then surged by 63.11% to -$491000.0 in 2023, then fell by 11.61% to -$548000.0 in 2024, then sank by 388.32% to -$2.7 million in 2025, then slipped by 0.56% to -$2.7 million in 2026.
• The last three Cash from Operations figures came in at -$2.7 million (Q2 2026), -$4.3 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.